Everything below concerns lyophilised powder. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-10-17. Numbers and descriptions here follow the published literature rather than marketing material.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
| Property | Value | Notes |
|---|---|---|
| Name type | Commercial trade name | Not a systematic chemical identifier |
| Parent peptide | Thymosin beta-4 | 43-residue natural peptide |
| Common fragment sequence | LKKTETQ | Maps to part of the actin-binding region |
| Molecular size class | Roughly 0.8-1.0 kDa | Depends on exact fragment and terminal modification |
| Regulatory status | Prohibited in sport | Grouped with peptide hormones in many frameworks |
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
The seven-residue chain carries several polar and charged side chains, so it dissolves readily in water and in aqueous buffers near neutral pH. No cysteine is present, so disulphide formation is not a concern and reducing agents are unnecessary. Dilute ammonium hydroxide or acetonitrile-water mixtures are sometimes used for stock solutions when initial dissolution is slow. Strongly alkaline conditions and prolonged contact with oxidising agents are avoided because they can modify lysine-containing stretches, and haze in solution usually signals incomplete dissolution or aggregated material.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
radiochemistry The branch of chemistry involving the study of radioactive substances and radioactivity, including the use of radioactive isotopes to study non-radioactive isotopes and ordinary chemical reactions.
The downfall of the overall cyclol model generally led to a rejection of its elements; one notable exception was J. D. Bernal's short-lived acceptance of the Langmuir-Wrinch hypothesis that protein folding is driven by hydrophobic association. Nevertheless, cyclol bonds were identified in small, naturally occurring cyclic peptides in the 1950s. Clarification of the modern terminology is appropriate. The classic cyclol reaction is the addition of the NH amine of a peptide group to the C=O carbonyl group of another; the resulting compound is now called an azacyclol. By analogy, an oxacyclol is formed when an OH hydroxyl group is added to a peptidyl carbonyl group. Likewise, a thiacyclol is formed by adding an SH thiol moiety to a peptidyl carbonyl group. The oxacyclol alkaloid ergotamine from the fungus Claviceps purpurea was the first identified cyclol. The cyclic depsipeptide serratamolide is also formed by an oxacyclol reaction. Chemically analogous cyclic thiacyclols have also been obtained. Classic azacyclols have been observed in small molecules and tripeptides. Peptides are naturally produced from the reversion of azacylols, a key prediction of the cyclol model. Hundreds of cyclol molecules have now been identified, despite Linus Pauling's calculation that such molecules should not exist because of their unfavorably high energy. After a long hiatus during which she worked mainly on the mathematics of X-ray crystallography, Wrinch responded to these discoveries with renewed enthusiasm for the cyclol model and its relevance in biochemistry.
But it was later discovered that this is only true for four of the fifteen lanthanides (lanthanum, cerium, gadolinium, and lutetium), and that the other lanthanide atoms do not have a d-electron. In particular, ytterbium completes the 4f shell and thus Soviet physicists Lev Landau and Evgeny Lifshitz noted in 1948 that lutetium is correctly regarded as a d-block rather than an f-block element; that bulk lanthanum is an f-metal was first suggested by Jun Kondō in 1963, on the grounds of its low-temperature superconductivity. This clarified the importance of looking at low-lying excited states of atoms that can play a role in chemical environments when classifying elements by block and positioning them on the table. Many authors subsequently rediscovered this correction based on physical, chemical, and electronic concerns and applied it to all the relevant elements, thus making group 3 contain scandium, yttrium, lutetium, and lawrencium and having lanthanum through ytterbium and actinium through nobelium as the f-block rows: this corrected version achieves consistency with the Madelung rule and vindicates Bassett, Werner, and Bury's initial chemical placement. In 1988, IUPAC released a report supporting this composition of group 3, a decision that was reaffirmed in 2021.
Sources: en.wikipedia.org
We Happy Few received "mixed or average" reviews, according to review aggregator website Metacritic. The audio was received positively, with the voice-acting being singled out for praise. Brittany Vincent of Shacknews elaborated that the characters' "stereotypical" accents along with the "peppy" music lent the game a "realistic lilt that make these weirdos even creepier". The performances for the three main characters were commended; Tyler Wilde of PC Gamer deemed the leads to be the game's great strength, describing them as "blending comedy and tragedy with calculated balance", and added that they spoke to themselves so naturally that Wilde nearly overlooked that they were "doing the videogame thing of saying everything out loud for no reason". Michael Huber of Easy Allies additionally cited the disconcerting effect of Uncle Jack's broadcasts. However, while Sam Spyrison of Hardcore Gamer agreed that the voice-acting was mostly solid, he felt that the dialogue was inconsistent, saying that it "ranges from original and enticing to disjointed and nonsensical". The music was appreciated, with Brian Shae of Game Informer and Caty McCarthy of USgamer singling out the use of distorted 1960s-style rock and roll music as a contribution to the game's haunting atmosphere. James Stephanie Sterling called the game "a joyless broken disaster" and suggested that it should be recalled. Sterling, having performed some minor voice-over work for the game during its crowdfunding phase, stated their embarrassment "for having the loosest of loose associations" with the final game.
== Terminology == Red yeast rice is also known as red fermented rice, red kojic rice or red koji rice from its Japanese name, and anka or angkak from Southern Min pronunciations of its Chinese name. In both the scientific and popular literature in English that draws principally on Japanese traditional use, red yeast rice is most often referred to as "red rice koji". English language articles favoring Chinese literature sources prefer the translation "red yeast rice".
== History == AOA1 was first described by Aicardi and colleagues in 1988. In 2001, Moreira and colleagues, and Date and colleaguees mapped the gene for AOA1 to 9p13 in Portuguese and Japanese populations.
==== Notes ==== Contains points of note, including explanation of titles and details of a legion's fate. Province names and borders are assumed throughout the Principate period as at 107, during the rule of Trajan, and after the annexation of Dacia and Arabia Petraea. The map above shows provinces at the end of Trajan's reign, 117. They are the same as in 107, except that Armenia and Mesopotamia have been annexed (they were abandoned soon after Trajan's death); and Pannonia has been split into two (the split occurred c. 107). In reality provincial borders were modified several times between 30 BC and 284: this explains any discrepancy with other sources, as to a legion's location at a particular date.
Sources: en.wikipedia.org
Contraindications of psychedelic drugs like mescaline include severe cardiovascular disease, epilepsy or seizures, schizophrenia and other psychotic disorders, bipolar disorder, and pregnancy, among others. Serotonin 5-HT2A receptor antagonists such as atypical antipsychotics and certain antidepressants may block psilocybin's hallucinogenic effects and hence may be considered contraindicated in this sense.
PEAKS and NovoHMM had the best sensitivity in both QSTAR and LCQ data as well. However, no evaluated algorithms exceeded a 50% of exact identification for both data sets. Recent progress in mass spectrometers made it possible to generate mass spectra of ultra-high resolution [1]. The improved accuracy, together with the increased amount of mass spectrometry data that are being generated, draws the interests of applying deep learning techniques to de novo peptide sequencing. In 2017 Tran et al. proposed DeepNovo, the first deep learning based de novo sequencing software. The benchmark analysis in the original publication demonstrated that DeepNovo outperformed previous methods, including PEAKS, Novor and PepNovo, by a significant margin. DeepNovo is implemented in python with the Tensorflow framework. To represent a mass spectrum as a fixed-dimensional input to the neural-network, DeepNovo discretized each spectrum into a length 150,000 vector. This unnecessarily large spectrum representation, and the single-thread CPU usage in the original implementation, prevents DeepNovo from performing peptide sequencing in real time. To further improve efficiency of de novo peptide sequencing models, Qiao et al. proposed PointNovo in 2020. PointNovo is a python software implemented with the PyTorch framework and it gets rid of the space consuming spectrum-vector-representation adopted by DeepNovo. Comparing with DeepNovo, PointNovo managed to achieve better accuracy and efficiency at the same time by directly representing a spectrum as a set of m/z and intensity pairs.
Modern food distribution in the United States is a result of continued growth since the 1960s. In an increasingly connected world, food distribution efforts in the US reach from coast to coast. A network of infrastructure, warehouses, factories, and commercial retailers comprise the bulk of US food distribution. It is estimated that food served in the United States may travel close to 1,500 miles between growers and consumers. While many products, specifically meat and grain, are distributed in different fashions, there are common trends to the distribution of most modern foods. An increase in the use of technology for farming has transformed the small local farm of the 1940s in to large production facilities. Several federal agencies, such as the US Department of Agriculture and the Food and Drug Administration, manage and sustain the productivity of the US food distribution system.
On January 4, 2008, the results of a mitochondrial DNA test, comparing the child's DNA with that of his potential grandmother, Clara de Rojas, were revealed by the Colombian government. It was reported that there was a very high probability that the boy was indeed part of the Rojas family. The same day, FARC released a communique in which they admitted that Emmanuel had been taken to Bogotá and "left in the care of honest persons" for safety reasons until a humanitarian exchange took place. The group accused President Uribe of "kidnapping" the child to sabotage his liberation. However, on January 10, 2008, FARC released Rojas and Gonzalez through a humanitarian commission headed by the International Committee of the Red Cross. On January 13, 2008, Venezuelan President Hugo Chávez stated his disapproval with the FARC strategy of armed struggle and kidnapping saying, "I don't agree with kidnapping and I don't agree with armed struggle". He repeated his call for a political solution and an end to the war in March and June 2008: "The guerrilla war is history...At this moment in Latin America, an armed guerrilla movement is out of place". In February 2008, FARC released four other political hostages "as a gesture of goodwill" toward Chávez, who had brokered the deal and sent Venezuelan helicopters with Red Cross logos into the Colombian jungle to pick up the freed hostages. On March 1, 2008, the Colombian armed forces launched a military operation 1.8 kilometres into Ecuador on a FARC position, killing 24, including Raúl Reyes, member of the FARC Central High Command.
In general, the reference range (that found in healthy young persons), is about 30–33 mmol/mol (4.9–5.2 DCCT %). The mean HbA1c for diabetics type 1 in Sweden in 2014 was 63 mmol/mol (7.9 DCCT%) and for type 2, 61 mmol/mol (7.7 DCCT%). HbA1c levels show a small, but statistically significant, progressive uptick with age; the clinical importance of this increase is unclear. A study indicated that it is possible to predict HbA1c values years in advance, by analyzing blood glucose patterns measured using continuous glucose monitors
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.
Published work usually examines actin binding, cell migration and tissue repair endpoints in cell and animal models. Findings are generally described as preliminary, and controlled human data remain limited.
Because TB-500 is a trade name rather than a chemical identifier, different vendors and papers may attach it to different fragment lengths. Checking the stated sequence is the practical way to resolve the ambiguity.
TB-500 is a trade-style label for a synthetic peptide connected to thymosin beta-4. It is sold mainly through research-chemical channels and is not a single chemically defined product across suppliers.